We would like to thank each of our sponsors for their generous support - as without them this event would not be possible.
- we supported more than 1200 commercial contract studies
- we recruited almost 35,000 patients into commercial contract studies
- 75% of the studies closing achieved 100% of their recruitment target within their planned timescales.
Funded by UK government, the National Institute for Health Research (NIHR) Clinical Research Network (CRN) is the clinical research delivery arm of the National Health Service (NHS) in England.
We support rapid study set-up and patient recruitment into all phases of clinical research studies, across all therapeutic areas. We’ve recruited over three million patients into clinical studies in the NHS over the last five years and created a thriving environment for conducting large scale commercial contract clinical research, so that companies can allocate clinical studies to the UK with confidence.
Last financial year:
At the core of these successes is our Study Support Service - a package of free-of-charge services covering the life cycle of a clinical study including feasibility, set-up, costings and contracts, and performance monitoring to enable recruitment to agreed time and target.
PRA Health Sciences delivers innovative drug development solutions that improve patients’ lives. Our people work tirelessly to provide quality results for clients. We offer specialized expertise across all phases, therapeutic areas and a broad spectrum of service models.
With 14,000+ employees covering 85+ countries, we deliver global presence combined with an in-depth knowledge of local regulations, standards of care and cultural customs.
At PRA, we love what do, because we are making a difference in the lives of patients and their family members worldwide. We have contributed to the development of numerous drugs now available to countless patients.
PSI is a privately-owned, full-service CRO, operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI is headquartered in Switzerland and its global reach supports the operations of clinical trials across multiple continents. PSI is known to be highly selective about the work they pursue. PSI has exceptionally high repeat and referral business rates, while maintaining minimal staff turnover indicative of its commitment to be the best CRO in the world as measured by its customers and its employees. www.psi-cro.com
PPD is delighted to sponsor PharmaTimes International Clinical Researcher of the Year 2018. PPD is a leading global contract research organisation providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organisations. With offices in 47 countries and approximately 20,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
Syneos HealthTM (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com.
Covance® and Chiltern, a Covance company, make the drug development business of LabCorp. As the world's most comprehensive drug development company, we are dedicated to advancing healthcare through a Designed Around You® experience and delivering Solutions Made Real®.
Our unique perspectives, built from decades of scientific expertise and precision delivery of the largest volume of drug development data in the world, helps our clients identify new approaches and anticipate tomorrow's challenges as they evolve. Together with our clients, we transform today's healthcare challenges into tomorrow's solutions. Information on our solutions can be obtained through our website at www.covance.com.